Understanding the mechanisms that regulate the development of complex mammalian organisms is one of the most fascinating problems in biology. The coordinated transcriptional regulation of specific sets of genes defines the framework upon which cell determination and differentiation are established. Thus, an understanding of tissue-specific gene transcription will significantly advance our knowledge of mammalian development. Lymphoid differentiation, the process by which committed progenitor cells give rise to both the T-and B-cell lineages, has long been used as a paradigm for studies of both tissue-specific and developmentally regulated gene expression. The following two papers review different aspects of transcriptional control during T-and B-cell development, focusing on two of the best-understood systems, namely the ~ TCR gene and the immunoglobulin genes. Both conclude that lymphocyte-specific gene expression is controlled by complex regulatory circuits involving interactions among multiple families of ubiquitous and lineage-specific transcription factors. 
reducing the normal 20 bp spacing to 15 bp eliminated enhancer activity, as did increasing the spacing to more than 85 bp. In contrast, the phasing of thc T~ 1 and "Fc,2 elements on the DNA helix did not appear to be critical; increasing the spacing from 20 to 25 bp had a relatively small effect on enhancer activity. Finally, the Tu3 and T~4 elements, while themselves not possessing high-level enhancer activity, could compensate for mutations m T~I or To,2 that abolished enhancer activity I'. Thus, T~3 and T(~4 represent redundant elements, at least as assayed in Jurkat T cells. It should be emphasized, however, that these results did not rule out the possibility that Tu3 and/or T~4 play an important role in modulating c~ TCR enhancer function at some earlier stage in ]'-cell development, or in response to specific extracellular signals. Taken together, these functional analyses revealed that the ~ TCR enhancer is composed of multiple, partiallv redundant, nuclear protein-binding sites. Interactions between proteins binding to these different sites appear to be important for enhancer function.
Transcription factors that regulate the activity of the 0~ TCR enhancer
An examination of the sequences of the nuclear protein-binding sites of the mouse and human ~ TCR enhancers revealed several previously described transcriptional regulatory elements (Fig. 2 ). For example, T(~I contains an evolutionarily-conserved cAMP response element (TGACGTCA) 1-'. Similarly, Tc~3 contains overlapping AP=2 (CCCCAGGC)-like j<w and KE2 (E box) (AGGCCACGTGCCGA)-like Ix motifs. In contrast, T(~2 and T(~4 do not contain previously identified nuclear protein-binding sites. Electrophoretic mobility shift assays (EMSAs), using synthetic oligonucleotides corresponding to Tcd-Tc~4, demonstrated that Tc~l binds a set of four to six ubiquitously expressed cAMP response element binding (CREB) proteins 1s,1~ within the core of the CRE and no T0d-binding proteins were detected that recognized non-CRE sequences (Ref.
19 and I-C. Ho and J.M. Leiden, unpublished) . Similar EMSAs demonstrated that T(x2 binds at least four nuclear protein complexes. One of these is T cell specific while a second is present in all T-cell, and some B-cell, nuclear extracts. Te~3 binds three nuclear protein complexes, one of which is T cell specific. Finally, T0~4 binds three ubiquitously expressed nuclear protein complexes. Interestingly, none of these experiments identified {xiB TCR lineage-specific nuclear protein complexes. More recent studies have focused on the cloning of transcription factors that bind to the (~ TCR enhancer. These factors are described individually below and their properties are summarized in Table 1 .
CREB proteins bind to Te~I
Southwestern screening of a/,gtl 1 cDNA expression library from human Jurkat T cells with a radiolabelled The identities of the additional one to three CREB proteins that bind to Tc~l, and the function of each of the CREB proteins in regulating T-cell transcription are unknown. As described in more detail below, a large number of T-cell enhancers and promoters contain CRE sites that are important for their transcriptional activity. Moreover, all T cells contain multiple CRE-binding proteins, although no T-cell-specific CREB protein has so far been identified. It is worth mentioning that the name CREB may be a misnomer. Although members of the CREB/ATF family of transcription factors are important in regulating transcription in response to alterations in intracellular cAMP levels, they also play important roles in modulating basal levels of transcription, and have recently been shown to upregulate transcription in response to alterations in intracellular calcium levels in neural cells 2r. Thus, their precise role in regulating transcription in T cells awaits studies using trans-dominant inhibitors and embryonic stem (ES) cell gene knock-out experiments, both m vitro and in vwo.
TCF/LEf" proteins brad to Ta2
Several recent reports have described the purification and cloning of two related transcription factors that bind to a pyrimidine-rich sequence (PyCTTTG/TT/AT/A) from the 5' end of Ta2 (as well as to a related motif in the CD3e enhancer) -'s +:. These two factors, called TCF-1 (Ref. 3 l) and TCF-I& + (or LEF-1 (Ref. 30)), are approximately 30kDa and 53-57kDa proteins containing closely related 80-90 amino acid DNA-binding domains that display significant homology to a region present in the high mobility group (HMG) family of DNA-binding proteins. Whereas LEF-I appears to be the mouse homolog of TCF-la, TCF-I is apparently encoded by a distinct gene. Studies of the expression patterns of these genes have demonstrated that LEF-1 is expressed during all stages of T-cell development, in both the a13 TCR and y8 TCR lineages, and in mouse pre-B cells ,~°. TCF-1 was reported to be expressed exclusively in T cells ~t but a comprehensive examination of TCF-1 expression at different stages of B-cell development has not yet been reported, and it is possible that it is also expressed transiently in early B cells. Overexpression of both TCF-1 and TCF-Ia/LEF-I in B cells, HeLa cells or COS cells leads to low level (3-20-fold) trans-activation of reporter constructs containing TCF-l-binding sites from the a TCR or Cl)3e enhancers -'') ~1. However, trans-activation bv LEF-1 and TCF-la appears to require the presence of additional nuclear protein-binding sites because overexpression of these factors cannot trans-activate a reporter construct containing only multimerized TCF/LEF-Ibinding sites upstream of a minimal promoter -'~'~°.
Multiple forms of both the TCF-1 and TCF-Ia/LEF-1 proteins appear to be generated by alternative splicing. These include variants of TCF-1, containing or lacking a proline-rich domain amino-terminal to the HMG box, as well as multiple forms of the protein with distinct carboxv-terminal regions, including one which is rich in serine and threonine residues ~1,;2. Similarly, two splice variants of TCF-l a have been described, which contain or lack a serine-threonine-rich domain, immediately amino-terminal to the HMG box >. The DNA-binding activities and trans-activation potentials of these alternatively spliced variants have not been studied in detail but it seems likely that the activities of these transcription factors may be regulated at both post-transcriptional and post-transl+ational levels.
Ets proteins bind to Tc~2
Using a hgtl I expression screening approach, Ho et al. ~ demonstrated that the protein product of the Ets-1 proto-oncogene binds specifically to a purine-rich sequence (GAGGATGTG) located at the 3' end of Ta2. Along with several simultaneous reports ~+-;s, this was the first demonstration that the Ets proto-oncogenes encode sequence-specific DNA-binding proteins. Binding of Ets-l to the (, TCR enhancer was especially intriguing because Ets-l is known to be expressed preferentially in thymocytes and T cells (as well as B cells)% and because its expression is developmentally regulated during thymic ontogeny, with a time course that is almost identical to that of the a TCR gene: both are first expressed on days 17 and 18 in the fetal mouse thymus 4''. Thus, Ets-1 is a candidate trigger factor for c~ TCR gene expression. The importance of the Ets-1-binding site for a TCR enhancer function was demonstrated by experiments showing that mutations in the core Ets-l-binding site in Ta2 abolished the activity of the minimal c, TCR enhancer in Jurkat cells ;~. Thus far, however, overexpression of Ets-I in B cells and in nonlymphoid cells has not resulted in the trans-activation of the a TCR enhancer (I-C. Ho and J.M. Leiden, unpublished) . This suggests that other T-cell-specific factors may be required for transactivation of the a TCR enhancer by Ets-1 (for example, TCF/LEF factors or GATA-3) or that other Ets family members may regulate the activity of the a TCR enhancer in T cells. (Evidence from several sources suggests that Ets proteins usually require additional transcription factors to communicate with the basal transcription machinery ~+.) Alternatively, the transcriptional activity of Ets-I may, require post-translational modification, and Ets-1 is known to exist in both phosphorvlated and nonphosphorylated forms in T cells 41.
Each of the Ets family members contains a conserved basic domain and an adjacent region with predicted a-helical structure 4e. Using deletion and mutation analyses, we have demonstrated that both of these conserved regions are necessary and sufficient for DNA binding (C-Y. Wang et al., submitted). Only two Ets family members, Ets-1 and Ets-2, were previously known to be expressed in T cells >. However, by using low stringency hybridization with a cDNA fragment encompassing the DNA-binding domain of 
GATA proteins that bind to Ta3
GATA-1 (previously called Eryf-1 and GF-1) is a zinc finger protein that is expressed exclusively in erythroid cells, megakaryocytes, mast cells and their common progenitors 44~7. This factor is a transcriptional activator that binds to a sequence, A/TGATAA/G, which is present in the transcriptional regulatory regions of a number of erythroid-specific genes including the a, 13 and 8 globin genes 48. Recent experiments, in which GATA-1 gene expression has been abolished by homologous recombination in embryonic stem cells, have demonstrated that GATA-1 is required for the development of the erythroid lineage in mice4L Thus, GATA-1 belongs to the small family of lineage-specific determination genes.
An examination of the Tc~3 motif of the ~ TCR enhancer revealed the presence of a consensus binding site (AGATAG) for GATA-1. Since GATA-1 is not expressed in T cells, this finding raised the possibility that there is a distinct T-cell GATA protein that binds to this site. To address this question, a Jurkat T-cell cDNA library was screened by low stringency hybridization with a cDNA probe from the zinc finger region of GATA-1. These experiments resulted in the isolation of a novel cDNA called hGATA-3 (Ref. 50 ). The chicken (cGATA-3) and mouse (mGATA-3) homologs of hGATA-3 were isolated using a similar approach sl,~2, hGATA-3 is a 48 kDa polypeptide that contains two zinc fingers that are more than 90% identical to those of GATA-1 (Ref. 50) . In contrast, the remainder of the protein is less than 12% identical to GATA-1. Studies of the expression pattern of hGATA-3 showed that, within hematopoietic cells, its expression is restricted to the (x13 and ~/~ T-cell lineages s°. Interestingly, a slightly larger GATA-3 mRNA is expressed in kidney and in some mesangial cell lines. The relationship between the kidney and T-cell GATA-3 mRNAs has not been established. Low level GATA-3 expression was also detected in whole brain. Overexpression of hGATA-3 (as well as cGATA-3 or mGATA-3) in nonlymphoid cells resulted in transactivation of reporter constructs containing multimerized GATA sites from Tcl3 (Ref. 50) or from a related sequence from the 8 TCR enhancer (~E4) s2 upstream of a minimal promoter. Thus, unlike the TCE-I(x/LEF-1 and the Ets proteins, hGATA-3 can trans-activate transcription from its cognate binding site in the absence of additional nuclear protein-binding sites.
An examination of mGATA-3 expression during thymocyte development has demonstrated expression of this gene in the earliest thymocytes tested (fetal day 14 in the mouse) (B.K. Oakley and J.M. Leiden, unpublished). Thus, like TCF-1 and TCF-IcdLEF-I, GATA-3 is a lineage-restricted transcription factor that is expressed very early in T-cell development, hGATA-3 was also shown to be expressed at low levels in CEM cells, an immature T-cell line that does not express c~ TCR mRNA. However, after stimulation with PMA both hGATA-3 and a TCR mRNA levels increased dramatically s(). (Similar findings have been reported for TCF-l(x in this systemZ~).) These findings, when considered with the previously described results concerning the role of GATA-I in erythroid differentiation 4~, suggested that GATA-3 is a good candidate for a T-cell-determining gene. This possibility is currently being tested by using homologous recombination to eliminate GATA-3 expression in embryonic stem cells and mice.
Shared nuclear protein-binding sites in multiple T-cell enhancers and promoters
The studies of the c~ TCR enhancer described above were predicated on the hypothesis that transcription factors that regulate c~ TCR gene expression might also regulate the expression of additional T-cell genes. This should be particularly true for factors that play important roles in regulating lymphoid and T-cell development. To address this question, the sequences of the known nuclear protein-binding sites from the c~ TCR enhancer have been compared with those of several other T-cellspecific transcriptional regulatory regions, including the human [31~ and ~,s~ TCR enhancers, the CD2 enhancer ~4, and the CD3e ss and ~s~ enhancers. As shown in Fig. 3 and Table 2 , each of these enhancers contains different combinations of binding sites for CREB, TCF-1/LEF-I, Ets, GATA and E box proteins. In some cases, these sites have been shown to bind the relevant proteins. Thus, the c~ TCR gene is an excellent paradigm of T-cell-specific transcriptional regulation, and it appears likely that each of these families of transcription factors plays an important role in regulating multiple T-cell genes during development. In addition, as shown in Table 2 , potential Ets-binding sites can also be found in the transcriptional regulatory regions of multiple lymphokine genes, suggesting that Ets family members may also play an important role in regulating gene expression during the process of T-cell activation; for example, at least one functional Ets-binding site is required for IL-2 enhancer function.
Many of the genes shown in Fig. 3 are expressed at different times in development, in some cases in different cell lineages, and, in others, only after cell activation. How, then, are these genes differentially regulated in response to distinct developmental and activational signals, if they contain common sets of nuclear proteinbinding sites? While the answer to this question is complex and not yet fully understood, there are several
TCF-1 Toc2B
Ets CD36 Enh --~ 247bp ~CCACTGAGC~T~C-- models that allow a significant redundancv in the cisacting regulatory sequences in different genes, while retaining the potential for differential expression.
First, different combinations of common, or overlapping, sets of nuclear protein-binding sites may allow flexible patterns of expression with a minimum number of different transcription factors. Such combinatorial divcrsitv is clearly, an important mechanism underlying the generation of antigen receptor diversity. This type of model is supported by the finding that interactions between transcription factors are required for the activity of many ot the T-cell-specific cnhancers.
Second, different members of a single family of transcription factors may display different DNA-binding specificities (which may be further modified by posttranscriptional or post-translational modifications) or may, bind preferentially to a given enhancer in combination with an adjacent nuclear protein. Such differences in DNA-binding specificities have already been dem(mstrated for the Ets family mcmbers and may explain how this single family of transcription factors regulates the expression of different genes in resting and activated T cells.
Third, it is possible that negative regulatory elements or silencers play an important role in restricting the lineage specificity of certain T-cell genes. This type of model is supported bv the inability to detect lineagespecific transcriptional activator proteins; all of the previously described o~ TCR enhancer binding proteins are expressed m both o~[3 TCR and y8 TCR T cells. Such transcriptional silencers may be distinct negative regulatory elements within these genes. This type of transcriptional silencer has been reported to downregulate the expression of the c~ TCR gene in non-c~[3 T cells s-and the y TCR ~s gene in non-y8 T cellsS~L Alternatively, the same multipartite transcriptional regulatory element may function as both a silencer and an enhancer, depending upon the particular set of nuclear proteins expressed by a given cell type. Such bifunctional transcriptional regulatory elements have bcen described in yeast `~+. Moreover, a reccnt studv has suggested that the To,2 motif from the human c, TCR enhancer can act as both a positive and negative transcriptional regulatory element, depending upon the precise DNA context in which it is located"".
Future directions
During the last few years, a great deal has been learned about the molecular mechanisms that regulate c, TCR gene expression during thvmocvte development. These data are sunmlari×ed schematicalh m Fig. 4 . The important cis-acting transcriptional activator sequcnces have been identified and characterized, and a set of novel transcription factors, some of which arc T cell specific, have been cloned. Several of these factors, including the CREB, TCF/t, EF, Ets and GATA proteins, also appear to play important roles in regulating the expression of multiplc genes during T-cell development and activation. Because they arc T cell specific and expressed very early during thymocyte ontogeny, the TCF/LEF and (,ATA-~:~ proteins arc particularly good candidates for T-celldetermining genes.
Although these studies have addressed a number of important questions concerning T-ceil development, they have raised at least as many questions as they have answered. First, several of the transcription factors that bind to the c, TCR enhancer have not vet been identified. In particular, there is evidence for a third factor that binds to To,2 (Tc~2B, Fig. 4 unpublished) and almost nothing is known about the identity of the Tu4-binding proteins. Moreover, it is not yet known which E-box-binding proteins are expressed in T cells. Given the importance of this family of transcription factors (the bHLH proteins such as E12/E47 and MyoD) in other developmental systems 61, this remains an important issue. Because each of the factors that has been shown to bind to the ot TCR enhancer belongs to a family of nuclear proteins, it remains unclear which of the family members is involved in regulating which gene at a given point in T-cell development. In addition, the available evidence suggests that many of these factors may themselves be regulated at the post-transcriptional and post-translational levels, and currently, relatively little about these processes is understood. The role of the enhancers and of silencers in determining lineage-specific gene expression is also not clear. Finally, almost nothing is known about what regulates the regulators, that is the mechanisms that regulate the expression of Ets-1, GATA-3, TCF-I or TCF-I(x/LEF-1 during thymocyte differentiation.
Over the next few years, gene knock-out experiments, using homologous recombination along with the expression of trans-dominant inhibitors in vitro and in vivo, should help to shed light on the function of the individual transcription factors. Biochemical studies should help to elucidate the post-transcriptional and post-translational regulation of these factors. Finally, studies of the transcriptional regulation of these transcription factors themselves may move us one step closer to identifying the true master switch gene(s) for the T-cell lineage. Given the current level of interest in these problems and the reagents now available, further insights into the molecular mechanisms underlying T-cell determination and differentiation can be expected in the near future.
